Semaglutide
GLP-1 receptor agonist (Ozempic, Wegovy)
A long-acting GLP-1 receptor agonist with a 168-hour half-life supporting weekly dosing. FDA-approved for type 2 diabetes (Ozempic) and chronic weight management (Wegovy). Drives appetite suppression via central GLP-1 receptor activity, delays gastric emptying, and improves insulin sensitivity. Standard protocol uses gradual 16-week titration to minimize GI side effects.
Quick reference
How Semaglutide works
Semaglutide binds the GLP-1 receptor in pancreatic β-cells (driving glucose-dependent insulin secretion), in the hypothalamic appetite centers (suppressing hunger and food noise), and in the gut (delaying gastric emptying → prolonged satiety). This is not a stimulant; it works by amplifying endogenous post-meal satiety signaling.
The 168-hour half-life comes from a fatty-acid side-chain that binds albumin, slowing renal clearance. This is why Semaglutide is weekly while older GLP-1s (liraglutide / Saxenda) require daily dosing.
Mechanistically, Semaglutide is not metabolic stimulation — it's appetite normalization. Most users describe loss of food noise / cravings rather than active appetite suppression. Caloric intake reduction of 300–700 kcal/day is typical at therapeutic doses.
In the DoseCraft framework, Semaglutide directly addresses Insulin Resistance (improved glycemic control) and Inflammation (GLP-1 receptor activity reduces pro-inflammatory cytokines).
Safety + side-effect profile
GI side effects are the dominant concern, especially during titration. Most resolve within 2–3 weeks at each dose level — patience and slow titration matter more than aggressive dose-stacking.
Documented serious risks: pancreatitis (rare, <1%), gallbladder issues at faster weight-loss rates, medullary thyroid carcinoma (theoretical, FDA boxed warning — contraindicated in MEN-2 / family history of MTC). Contraindications: type 1 diabetes, severe gastroparesis, active gallbladder disease, pregnancy, breastfeeding.
Critical interactions: never stack with another GLP-1 agonist (Tirzepatide, Liraglutide, Retatrutide) — compounds GI side effects with no added efficacy. Caution with sulfonylureas and insulin (hypoglycemia risk) — those medications often need dose reduction. Birth control absorption can be reduced during slow gastric emptying — use backup contraception during titration.
Lean mass preservation: Semaglutide-associated rapid weight loss is typically 30–40% lean mass without intervention. Resistance training + 1.6–2.2 g protein per kg bodyweight per day maintains this at 10–15% lean mass loss. This is non-negotiable for long-term outcomes.
- • Nausea (very common, 40–50% in first 4 weeks; usually resolves)
- • Constipation or diarrhea (alternating common)
- • Reflux / GERD (especially if eating large meals)
- • Fatigue in first 2–4 weeks
- • Loss of food noise (intended effect)
- • Reduced alcohol cravings (commonly reported, secondary effect)
Frequently asked
What is Semaglutide?
Semaglutide is a long-acting GLP-1 receptor agonist with a 168-hour half-life supporting once-weekly dosing. FDA-approved for type 2 diabetes (Ozempic, since 2017) and chronic weight management (Wegovy, since 2021). Drives appetite suppression and improves insulin sensitivity.
What is the standard Semaglutide titration?
Standard 16-week titration: 0.25 mg weekly × 4 weeks → 0.5 mg × 4 weeks → 1.0 mg × 4 weeks → 1.7 mg × 4 weeks → 2.4 mg maintenance. For T2D, target is often 0.5–2 mg. For weight loss, target is 1.7–2.4 mg. Slow titration is critical to minimize GI side effects.
Should I stack Semaglutide with Tirzepatide or Retatrutide?
No. All three are GLP-1 receptor agonists (Tirzepatide and Retatrutide are dual/triple agonists that also include GIP and glucagon receptor activity). Stacking them compounds GI side effects with zero added efficacy — choose one. Tirzepatide is generally more potent for weight loss; Retatrutide (in trials) is the most powerful but not FDA-approved.
How fast will I lose weight on Semaglutide?
Average weight loss in clinical trials at 68 weeks: 14.9% of bodyweight (Wegovy STEP 1 trial) at 2.4 mg weekly. Practitioner reality: most users see 1–2 lbs/week during active titration, slowing to 0.5–1 lb/week at maintenance dose. Faster loss is possible but linked to higher gallbladder issue rates and aggressive lean mass loss.
How do I preserve lean mass on Semaglutide?
Resistance training 3–4× per week + 1.6–2.2 g protein per kg bodyweight per day. Without intervention, ~30–40% of lost weight is lean mass; with this protocol, lean mass loss drops to 10–15%. This is non-negotiable for long-term metabolic health and physique outcomes.
Can I drink alcohol on Semaglutide?
Alcohol cravings drop substantially for most users — this is a well-documented secondary effect (currently in clinical trials for AUD). Drinking is not contraindicated, but tolerance often decreases (you'll feel one drink like two). Heavy drinking compounds GI side effects.
What happens when I stop Semaglutide?
Without lifestyle intervention, weight regain is common — clinical trials show ~67% of lost weight returns within 1 year of cessation. Practitioner approach: taper rather than stop cold (drop dose by half for 4–8 weeks before stopping), maintain protein + resistance training habits, and accept that for chronic obesity Semaglutide is closer to insulin-for-T1D than a short-term diet drug.
Are there long-term safety concerns?
Currently 8+ years of cumulative safety data from the Ozempic indication. Documented risks: pancreatitis (rare, <1%), gallbladder issues (3–6%), MTC theoretical (FDA boxed warning, contraindicated in MEN-2 / family history). Long-term GI motility effects are still being characterized. Generally considered safe for chronic use under physician supervision.
Protocols using Semaglutide
Outcome-driven stacks with phased dose schedules and cited PMIDs.
Head-to-head comparisons
Cited side-by-side breakdowns that include Semaglutide.
Related compounds
Often researched, stacked, or compared with Semaglutide.
Build your Semaglutide protocol with Coach
Coach personalizes the dose, stack, and cycle for your specific goals — and saves the result as a cited PDF you can bring to your doctor. Free for 14 days.
Start 14-Day Free TrialNo credit card · cancel anytime